Yvette Taché Selected Research

Peptides (Polypeptides)

11/2022	Peripheral CRF-R1/CRF-R2 antagonist, astressin C, induces a long-lasting blockade of acute stress-related visceral pain in male and female rats.
1/2015	Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice.
12/2014	Brain peptides and the modulation of postoperative gastric ileus.
1/2013	Role of brain NUCB2/nesfatin-1 in the regulation of food intake.
4/2011	Chronic injection of pansomatostatin agonist ODT8-SST differentially modulates food intake and decreases body weight gain in lean and diet-induced obese rats.
6/2010	Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis.
12/2009	Regulation of food intake: the gastric X/A-like endocrine cell in the spotlight.
3/2009	Nesfatin-1 immunoreactivity in rat brain and spinal cord autonomic nuclei.
3/2005	CCK inhibits the orexigenic effect of peripheral ghrelin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yvette Taché Research Topics

Disease

13	Body Weight (Weight, Body) 01/2020 - 03/2009
10	Visceral Pain 02/2024 - 10/2004
10	Hyperalgesia 01/2019 - 09/2003
9	Hypersensitivity (Allergy) 11/2022 - 09/2005
7	Ileus 01/2023 - 02/2003
7	Diarrhea 11/2021 - 01/2002
7	AIDS-Related Complex (ARC) 01/2011 - 05/2002
6	Inflammation (Inflammations) 01/2023 - 01/2010
5	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2015 - 01/2002
4	Obesity 10/2017 - 08/2003
3	Parkinson Disease (Parkinson's Disease) 01/2019 - 05/2008
2	Nociceptive Pain 02/2024 - 01/2012
2	Neuroinflammatory Diseases 03/2022 - 10/2017
2	Pain (Aches) 01/2018 - 10/2017
2	Colitis 10/2015 - 06/2010
2	Ulcerative Colitis 03/2013 - 11/2012
2	Infections 09/2011 - 09/2010
2	Atrophy 02/2011 - 03/2010
2	Cushing Syndrome 02/2011 - 03/2010
1	Opioid-Induced Constipation 01/2023
1	Constipation 01/2023
1	Dysbiosis 03/2022
1	Chronic Pain 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 10/2017
1	Anorexia 01/2015
1	Gastroparesis 05/2014
1	Insulin Resistance 09/2013

Drug/Important Bio-Agent (IBA)

11	GhrelinIBA 01/2023 - 05/2002
11	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 03/2013 - 01/2002
9	Peptides (Polypeptides)IBA 11/2022 - 03/2005
9	Corticotropin-Releasing HormoneIBA 01/2018 - 01/2002
7	CRF receptor type 1IBA 01/2018 - 01/2002
4	astressinIBA 11/2022 - 05/2002
4	8-sulfocholecystokinin octapeptideIBA 10/2017 - 03/2005
3	Opioid Analgesics (Opioids)IBA 02/2024 - 01/2018
3	CytokinesIBA 01/2023 - 06/2010
3	astressin BIBA 11/2021 - 02/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 09/2013
3	Analgesics (Analgesic Drugs)IBA 01/2019 - 07/2011
3	CorticosteroneIBA 01/2017 - 03/2010
3	Hormones (Hormone)IBA 01/2017 - 06/2010
3	Serotonin (5 Hydroxytryptamine)IBA 01/2015 - 01/2010
2	Thyrotropin-Releasing Hormone (Protirelin)FDA Link 02/2024 - 11/2002
2	L- pyroglutamyl- L- histidyl- 3,3- dimethylprolinamideIBA 02/2024 - 10/2017
2	HM01IBA 01/2023 - 01/2019
2	Cholinergic Agents (Cholinergics)IBA 01/2023 - 01/2023
2	Blood Glucose (Blood Sugar)IBA 10/2017 - 01/2016
2	EnzymesIBA 01/2017 - 05/2014
2	acyl-ghrelinIBA 01/2017 - 08/2011
2	Dextrans (Dextran)FDA Link 10/2015 - 06/2010
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2015 - 06/2010
2	Gonadal HormonesIBA 09/2015 - 01/2010
2	liu-jun-zi-tangIBA 01/2015 - 05/2014
2	cortagineIBA 01/2015 - 07/2009
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2015 - 04/2011
2	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2014 - 09/2005
2	CRF receptor type 2IBA 03/2013 - 07/2005
2	Messenger RNA (mRNA)IBA 11/2012 - 05/2002
2	LipopolysaccharidesIBA 09/2011 - 09/2010
2	TOR Serine-Threonine KinasesIBA 01/2011 - 02/2010
2	Proteins (Proteins, Gene)FDA Link 02/2010 - 05/2008
2	Neuropeptide YIBA 02/2010 - 05/2002
2	Estrogens (Estrogen)FDA Link 01/2010 - 09/2005
2	Dimenhydrinate (DMH)FDA LinkGeneric 04/2008 - 10/2006
2	CP 154526IBA 04/2008 - 05/2002
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	Opiate AlkaloidsIBA 01/2023
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	SynucleinsIBA 03/2022
1	Amyloid (Amyloid Fibrils)IBA 03/2022
1	Protein AggregatesIBA 03/2022
1	tocinoic acidIBA 01/2019
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2018
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2018
1	ProstaglandinsIBA 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	TrypsinIBA 10/2017
1	Cholecystokinin (Pancreozymin)IBA 10/2017
1	Peptide Hydrolases (Proteases)FDA Link 10/2017
1	16S Ribosomal RNAIBA 01/2017
1	fluorescein isothiocyanate dextranIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	LeptinIBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015
1	Complement System Proteins (Complement)IBA 09/2015
1	Carboxy-LyasesIBA 05/2014
1	Carbidopa (Lodosyn)FDA LinkGeneric 05/2014
1	Amino Acids FDA Link 05/2014
1	Levodopa (L Dopa)FDA LinkGeneric 05/2014
1	AntralIBA 05/2014
1	Dopamine (Intropin)FDA LinkGeneric 05/2014
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 09/2013
1	5- (6- isopropyl- 2- methylaminopyridin- 3- yl)- (N- (1- ethyl)propyl)- 3- methoxy- 6- methylpyrazine- 2- amineIBA 01/2013

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2012
2	High-Protein Diet 10/2017 - 09/2013
2	Kampo Medicine (Kampo) 01/2015 - 05/2014
2	Analgesia 01/2012 - 01/2012
1	Spinal Injections 01/2018